Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome.

Al-Radaideh AM, Wharton SJ, Lim SY, Tench CR, Morgan PS, Bowtell RW, Constantinescu CS, Gowland PA.

Mult Scler. 2013 Jun;19(7):896-903. doi: 10.1177/1352458512465135.

PMID:
23139386
2.

Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.

Khalil M, Langkammer C, Pichler A, Pinter D, Gattringer T, Bachmaier G, Ropele S, Fuchs S, Enzinger C, Fazekas F.

Neurology. 2015 Jun 16;84(24):2396-402. doi: 10.1212/WNL.0000000000001679.

PMID:
25979698
3.

Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging.

Ge Y, Jensen JH, Lu H, Helpern JA, Miles L, Inglese M, Babb JS, Herbert J, Grossman RI.

AJNR Am J Neuroradiol. 2007 Oct;28(9):1639-44.

4.

Iron deposition in the precentral grey matter in patients with multiple sclerosis: a quantitative study using susceptibility-weighted imaging.

Rumzan R, Wang JJ, Zeng C, Chen X, Li Y, Luo T, Lv F, Wang ZP, Hou H, Huang F.

Eur J Radiol. 2013 Feb;82(2):e95-9. doi: 10.1016/j.ejrad.2012.09.006.

PMID:
23079047
5.

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.

Zivadinov R, Heininen-Brown M, Schirda CV, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Hagemeier J, Benedict RH, Weinstock-Guttman B, Dwyer MG.

Neuroimage. 2012 Jan 2;59(1):331-9. doi: 10.1016/j.neuroimage.2011.07.045.

PMID:
21820063
6.

Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.

Lim IA, Faria AV, Li X, Hsu JT, Airan RD, Mori S, van Zijl PC.

Neuroimage. 2013 Nov 15;82:449-69. doi: 10.1016/j.neuroimage.2013.05.127.

7.

Susceptibility phase imaging with comparison to R2 mapping of iron-rich deep grey matter.

Walsh AJ, Wilman AH.

Neuroimage. 2011 Jul 15;57(2):452-61. doi: 10.1016/j.neuroimage.2011.04.017.

PMID:
21513807
8.

Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease.

Walsh AJ, Blevins G, Lebel RM, Seres P, Emery DJ, Wilman AH.

Radiology. 2014 Jan;270(1):186-96. doi: 10.1148/radiol.13130474.

PMID:
23925273
9.

Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.

Deppe M, Marinell J, Krämer J, Duning T, Ruck T, Simon OJ, Zipp F, Wiendl H, Meuth SG.

Neuroimage Clin. 2014 Mar 3;6:475-87. doi: 10.1016/j.nicl.2014.02.012.

10.

Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy.

Hagemeier J, Weinstock-Guttman B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Magnano C, Hojnacki D, Dwyer MG, Zivadinov R.

AJNR Am J Neuroradiol. 2012 Sep;33(8):1596-601. doi: 10.3174/ajnr.A3030.

11.

Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: a 7 Tesla MRI study.

Blazejewska AI, Al-Radaideh AM, Wharton S, Lim SY, Bowtell RW, Constantinescu CS, Gowland PA.

J Magn Reson Imaging. 2015 Apr;41(4):1065-70. doi: 10.1002/jmri.24644.

PMID:
24841344
12.

Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study.

Zivadinov R, Schirda C, Dwyer MG, Haacke ME, Weinstock-Guttman B, Menegatti E, Heininen-Brown M, Magnano C, Malagoni AM, Wack DS, Hojnacki D, Kennedy C, Carl E, Bergsland N, Hussein S, Poloni G, Bartolomei I, Salvi F, Zamboni P.

Int Angiol. 2010 Apr;29(2):158-75.

PMID:
20351672
13.

MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping.

Bilgic B, Pfefferbaum A, Rohlfing T, Sullivan EV, Adalsteinsson E.

Neuroimage. 2012 Feb 1;59(3):2625-35. doi: 10.1016/j.neuroimage.2011.08.077.

14.

Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).

Du S, Sah SK, Zeng C, Wang J, Liu Y, Xiong H, Li Y.

Eur J Radiol. 2015 Jul;84(7):1325-32. doi: 10.1016/j.ejrad.2015.04.013.

PMID:
25959392
15.

Multiple sclerosis: improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging.

Rudko DA, Solovey I, Gati JS, Kremenchutzky M, Menon RS.

Radiology. 2014 Sep;272(3):851-64. doi: 10.1148/radiol.14132475.

PMID:
24828000
16.

Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength.

Deistung A, Schäfer A, Schweser F, Biedermann U, Turner R, Reichenbach JR.

Neuroimage. 2013 Jan 15;65:299-314. doi: 10.1016/j.neuroimage.2012.09.055.

PMID:
23036448
17.

Elevated brain iron is independent from atrophy in Huntington's Disease.

Dumas EM, Versluis MJ, van den Bogaard SJ, van Osch MJ, Hart EP, van Roon-Mom WM, van Buchem MA, Webb AG, van der Grond J, Roos RA; TRACK-HD investigators..

Neuroimage. 2012 Jul 2;61(3):558-64. doi: 10.1016/j.neuroimage.2012.03.056.

PMID:
22480728
18.

Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.

Khalil M, Enzinger C, Langkammer C, Tscherner M, Wallner-Blazek M, Jehna M, Ropele S, Fuchs S, Fazekas F.

Mult Scler. 2009 Sep;15(9):1048-54. doi: 10.1177/1352458509106609.

PMID:
19556316
19.

Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis.

Ceccarelli A, Rocca MA, Perego E, Moiola L, Ghezzi A, Martinelli V, Comi G, Filippi M.

Mult Scler. 2011 Jun;17(6):702-7. doi: 10.1177/1352458510395645.

PMID:
21228024
20.

Iron deposition of the deep grey matter in patients with multiple sclerosis and neuromyelitis optica: a control quantitative study by 3D-enhanced susceptibility-weighted angiography (ESWAN).

Chen X, Zeng C, Luo T, Ouyang Y, Lv F, Rumzan R, Wang Z, Li Q, Wang J, Hou H, Huang F, Li Y.

Eur J Radiol. 2012 Apr;81(4):e633-9. doi: 10.1016/j.ejrad.2012.01.003.

PMID:
22280874
Items per page

Supplemental Content

Support Center